Manna S[Author] - Search Results

Year	Number of Results
1953	2
1960	1
1961	2
1968	1
1971	1
1972	1
1974	1
1975	1
1983	7
1984	1
1985	3
1986	1
1987	4
1989	2
1990	1
1991	3
1992	3
1993	2
1994	3
1995	3
1996	3
1997	4
1998	7
1999	10
2000	15
2001	3
2002	5
2003	13
2004	8
2005	10
2006	19
2007	7
2008	9
2009	18
2010	18
2011	19
2012	20
2013	40
2014	30
2015	37
2016	38
2017	26
2018	36
2019	43
2020	62
2021	13

1

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.

Laha S, Chakraborty J, Das S, Manna SK, Biswas S, Chatterjee R. Laha S, et al. Among authors: manna sk. Infect Genet Evol. 2020 Nov;85:104445. doi: 10.1016/j.meegid.2020.104445. Epub 2020 Jun 30. Infect Genet Evol. 2020. PMID: 32615316 Free PMC article.

2

Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19.

Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, Jacobi A, Chung M, Bernheim A, Eber C, Concepcion J, Fayad ZA, Gupta YS. Toussie D, et al. Among authors: manna s. Radiology. 2020 Oct;297(1):E197-E206. doi: 10.1148/radiol.2020201754. Epub 2020 May 14. Radiology. 2020. PMID: 32407255 Free PMC article.

3

Placental Ageing in Adverse Pregnancy Outcomes: Telomere Shortening, Cell Senescence, and Mitochondrial Dysfunction.

Manna S, McCarthy C, McCarthy FP. Manna S, et al. Oxid Med Cell Longev. 2019 May 22;2019:3095383. doi: 10.1155/2019/3095383. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31249642 Free PMC article. Review.

4

Clinical Characteristics of Hospitalized Covid-19 Patients in New York City.

Paranjpe I, Russak A, De Freitas JK, Lala A, Miotto R, Vaid A, Johnson KW, Danieletto M, Golden E, Meyer D, Singh M, Somani S, Manna S, Nangia U, Kapoor A, O'Hagan R, O'Reilly PF, Huckins LM, Glowe P, Kia A, Timsina P, Freeman RM, Levin MA, Jhang J, Firpo A, Kovatch P, Finkelstein J, Aberg JA, Bagiella E, Horowitz CR, Murphy B, Fayad ZA, Narula J, Nestler EJ, Fuster V, Cordon-Cardo C, Charney DS, Reich DL, Just AC, Bottinger EP, Charney AW, Glicksberg BS, Nadkarni G. Paranjpe I, et al. Among authors: manna s. medRxiv. 2020 Apr 23:2020.04.19.20062117. doi: 10.1101/2020.04.19.20062117. Preprint. medRxiv. 2020. PMID: 32511655 Free PMC article.

5

Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells.

Manna SK, Gangadharan C, Edupalli D, Raviprakash N, Navneetha T, Mahali S, Thoh M. Manna SK, et al. J Biol Chem. 2013 Mar 22;288(12):8562. doi: 10.1074/jbc.A113.191916. J Biol Chem. 2013. PMID: 23526248 Free PMC article. No abstract available.

6

Azadirachtin interacts with retinoic acid receptors and inhibits retinoic acid-mediated biological responses.

Thoh M, Babajan B, Raghavendra PB, Sureshkumar C, Manna SK. Thoh M, et al. Among authors: manna sk. J Biol Chem. 2013 Mar 22;288(12):8563. doi: 10.1074/jbc.A113.169334. J Biol Chem. 2013. PMID: 23526249 Free PMC article. No abstract available.

7

Spontaneous subcutaneous emphysema and pneumomediastinum in non-intubated patients with COVID-19.

Manna S, Maron SZ, Cedillo MA, Voutsinas N, Toussie D, Finkelstein M, Steinberger S, Chung M, Bernheim A, Eber C, Gupta YS, Concepcion J, Libes R, Jacobi A. Manna S, et al. Clin Imaging. 2020 Nov;67:207-213. doi: 10.1016/j.clinimag.2020.08.013. Epub 2020 Aug 26. Clin Imaging. 2020. PMID: 32871424 Free PMC article.

8

Retraction: Inhibition of RelA phosphorylation sensitizes chemotherapeutic agents-mediated apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells.

Manna SK, Manna P, Sarkar A. Manna SK, et al. Cell Death Differ. 2013 May;20(5):784. doi: 10.1038/cdd.2013.18. Epub 2013 Mar 1. Cell Death Differ. 2013. PMID: 23449392 Free PMC article. No abstract available.

9

Azadirachtin interacts with the tumor necrosis factor (TNF) binding domain of its receptors and inhibits TNF-induced biological responses.

Thoh M, Kumar P, Nagarajaram HA, Manna SK. Thoh M, et al. Among authors: manna sk. J Biol Chem. 2013 Mar 22;288(12):8561. doi: 10.1074/jbc.A113.065847. J Biol Chem. 2013. PMID: 23526247 Free PMC article. No abstract available.

10

Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.

Lu T, Wang S, Xu L, Zhou Q, Singla N, Gao J, Manna S, Pop L, Xie Z, Chen M, Luke JJ, Brugarolas J, Hannan R, Wang T. Lu T, et al. Among authors: manna s. Sci Immunol. 2020 Feb 21;5(44):eaaz3199. doi: 10.1126/sciimmunol.aaz3199. Sci Immunol. 2020. PMID: 32086382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results